Return to study ST001251 main page
MB Sample ID: SA091110
Local Sample ID: | 17_27 _t_60 |
Subject ID: | SU001319 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Age Or Age Range: | 19-27 |
Weight Or Weight Range: | 58-92 |
Height Or Height Range: | 172-190 |
Gender: | Male |
Human Race: | Caucasian |
Human Trial Type: | Prospective randomized open label controlled intervention study |
Human Medications: | None |
Human Prescription Otc: | None |
Human Smoking Status: | Non smoker |
Human Alcohol Drug Use: | Not in |
Human Nutrition: | Fasted for 12 hours before the first sample was obtained. |
Human Inclusion Criteria: | Healthy (normal physical examination, electrocardiography, and routine laboratory values). |
Human Exclusion Criteria: | Febrile illness during the 2 weeks before the endotoxemia experiment, taking any prescription medication, history of spontaneous vagal collapse, practicing or experience with any kind of meditation, or participation in a previous trial where LPS was administered. |
Select appropriate tab below to view additional metadata details:
Combined analysis:
Analysis ID | AN002077 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Agilent 1290 |
Column | Discovery HS F5-3 (15cm x 2.1 mm,3um) Supelco,Sigma Aldrich) |
MS Type | ESI |
MS instrument type | QTOF |
MS instrument name | Agilent 6540 QTOF |
Ion Mode | UNSPECIFIED |
Units | relative abundance |
Chromatography:
Chromatography ID: | CH001514 |
Instrument Name: | Agilent 1290 |
Column Name: | Discovery HS F5-3 (15cm x 2.1 mm,3um) Supelco,Sigma Aldrich) |
Flow Gradient: | 5% B from 0-0.1min to 35% B at 1.5 min, to 95% B at 2.05 min which was kept constant until 3.2 min, to 5% B at 3.21 min and washing until 4.3 min with 5% B. |
Flow Rate: | The flow rate was kept constant at 700 µL/min from 0 min to 2.2 min, and increased up to 900 µL/min from 2.2 min to 2.5 min, after which flow rate was kept constant until 3.2 min.The flow rate was decreased from 900 µL/min to 800 µL/min from 3.2 min to 3.1 min and kept constant until 3.7 min, when flow rate was changed to 700 µL/min. |
Injection Temperature: | 40 °C |
Solvent A: | 95% water/5% acetonitrile; 0.1% formic acid; 10 mM ammonium formate |
Solvent B: | 95% acetonitrile/5% water; 0.1% formic acid; 10 mM ammonium formate |
Chromatography Type: | Reversed phase |